Literature DB >> 18636477

Coronary vasospasm produces reversible perfusion defects observed during adenosine triphosphate stress myocardial single-photon emission computed tomography.

Hiroki Teragawa1, Kentaro Ueda, Koichiro Okuhara, Rieko Kuwashima, Yukihiro Fukuda, Masao Kiguchi, Kingo Taniguchi, Yukihito Higashi, Tetsuya Oshima, Masao Yoshizumi, Kazuaki Chayama.   

Abstract

BACKGROUND: Adenosine triphosphate stress thallium-201 single-photon emission computed tomography (ATP-SPECT) is useful for diagnosing coronary artery disease (CAD), although sometimes false positive results are observed. It has not been established whether a coronary spasm is responsible for the false positive findings during ATP-SPECT. HYPOTHESIS: We investigated whether coronary spasm is one of the factors which produces reversible defects on ATP-SPECT.
METHODS: Eighty-six patients (mean age: 62 y; 58 men) who underwent both spasm-provocation testing by coronary angiography and ATP-SPECT, were selected for the study. Patients with coronary narrowing (>30%), myocardial infarction, or heart failure were excluded. Patients were divided into 2 groups based on whether the spasm-provocation test result was positive (vasospastic angina [VSA] group, n = 46) or negative (non-VSA group, n = 39).
RESULTS: The body mass index was lower in the VSA group than in the non-VSA group (p = 0.005). On ATP-SPECT imaging, any type of reversible defect was observed more frequently in the VSA group (68%) than in the non-VSA group (36%, p = 0.0027). Logistic regression analysis demonstrated that the presence of reversible defects was one of the factors accounting for the presence of coronary vasospasm (p = 0.0022, R2 = 0.172).
CONCLUSIONS: The findings suggest that reversible defects on ATP-SPECT imaging are frequently present in patients with coronary vasospasm. Coronary spasm may be considered as 1 of the factors, which produce reversible defects on ATP-SPECT, observed in patients with chest symptoms and angiographically normal coronary arteries. Copyright (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636477      PMCID: PMC6653485          DOI: 10.1002/clc.20217

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  26 in total

1.  Dipyridamole-induced reversible thallium-201 defect in patients with vasospastic angina and nearly normal coronary arteries.

Authors:  H Fujita; H Yamabe; M Yokoyama
Journal:  Clin Cardiol       Date:  2000-01       Impact factor: 2.882

2.  Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy.

Authors:  S Hamasaki; J Al Suwaidi; S T Higano; K Miyauchi; D R Holmes; A Lerman
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

3.  Assessment of the severity of coronary artery stenosis by the ratio of the regional washout rate determined by adenosine triphosphate stress Tl-201 SPECT.

Authors:  H Teragawa; T Yamagata; M Kato; M Hiraga; H Matsuura; G Kajiyama
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

4.  The preventive effect of magnesium on coronary spasm in patients with vasospastic angina.

Authors:  H Teragawa; M Kato; T Yamagata; H Matsuura; G Kajiyama
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

5.  Prognostic value of myocardial perfusion imaging with adenosine triphosphate.

Authors:  Nieves Bravo; Marta Giménez; Sergio Mejía; María José García-Velloso; Isabel Coma-Canella
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

6.  Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation.

Authors:  Daniel S Berman; Aiden Abidov; Xingping Kang; Sean W Hayes; John D Friedman; Maria G Sciammarella; Ishac Cohen; James Gerlach; Parker B Waechter; Guido Germano; Rory Hachamovitch
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

7.  Myocardial bridging increases the risk of coronary spasm.

Authors:  Hiroki Teragawa; Yukihiro Fukuda; Keiji Matsuda; Hidekazu Hirao; Yukihito Higashi; Togo Yamagata; Tetsuya Oshima; Hideo Matsuura; Kazuaki Chayama
Journal:  Clin Cardiol       Date:  2003-08       Impact factor: 2.882

8.  Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers.

Authors:  Akira Ito; Yoshihiro Fukumoto; Hiroaki Shimokawa
Journal:  J Cardiovasc Pharmacol       Date:  2004-10       Impact factor: 3.105

9.  Coronary flow reserve in patients with vasospastic angina: correlation between coronary flow reserve and age or duration of angina.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Tadao Uraoka
Journal:  Coron Artery Dis       Date:  2003-09       Impact factor: 1.439

10.  Exercise-induced silent myocardial ischemia in patients with vasospastic angina.

Authors:  M Aoki; S Koyanagi; K Sakai; T Irie; A Takeshita; M Nakamura; O Nakagaki
Journal:  Am Heart J       Date:  1990-03       Impact factor: 4.749

View more
  1 in total

Review 1.  Non-invasive diagnosis of vasospastic angina.

Authors:  Vincent Ngo; Anahita Tavoosi; Alexandre Natalis; Francois Harel; E Marc Jolicoeur; Robert S B Beanlands; Matthieu Pelletier-Galarneau
Journal:  J Nucl Cardiol       Date:  2022-03-23       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.